These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31432614)

  • 1. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
    Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
    HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland.
    Etoori D; Ciglenecki I; Ndlangamandla M; Edwards CG; Jobanputra K; Pasipamire M; Maphalala G; Yang C; Zabsonre I; Kabore SM; Goiri J; Teck R; Kerschberger B
    J Int AIDS Soc; 2018 Oct; 21(10):e25194. PubMed ID: 30350392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
    Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
    AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.
    Jiamsakul A; Sungkanuparph S; Law M; Kantor R; Praparattanapan J; Li PC; Phanuphak P; Merati T; Ratanasuwan W; Lee CK; Ditangco R; Mustafa M; Singtoroj T; Kiertiburanakul S;
    J Int AIDS Soc; 2014; 17(1):19053. PubMed ID: 25141905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
    Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
    Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda.
    Omooja J; Nannyonjo M; Sanyu G; Nabirye SE; Nassolo F; Lunkuse S; Kapaata A; Segujja F; Kateete DP; Ssebaggala E; Bbosa N; Aling E; Nsubuga RN; Kaleebu P; Ssemwanga D
    J Antimicrob Chemother; 2019 Oct; 74(10):3021-3029. PubMed ID: 31257432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
    Khan S; Das M; Andries A; Deshpande A; Mansoor H; Saranchuk P; Isaakidis P
    Glob Health Action; 2014; 7():24861. PubMed ID: 25084835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland.
    Bachmann N; von Braun A; Labhardt ND; Kadelka C; Günthard HF; Sekaggya-Wiltshire C; Castelnuovo B; Kambugu A; Lejone TI; Böni J; Yerly S; Perreau M; Klimkait T; Kouyos RD; Fehr J;
    J Antimicrob Chemother; 2019 Feb; 74(2):468-472. PubMed ID: 30476115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011.
    Kazooba P; Mayanja BN; Levin J; Masiira B; Kaleebu P
    Pan Afr Med J; 2018; 29():191. PubMed ID: 30061969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda: A prospective cohort study.
    Nanfuka M; Forrest JI; Zhang W; Okoboi S; Birungi J; Kaleebu P; Zhu J; Tibenganas S; Moore DM
    Medicine (Baltimore); 2021 May; 100(19):e25763. PubMed ID: 34106606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage to intensive adherence counselling among HIV-positive persons on ART with detectable viral load in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Debem H; Kiwanuka G; Kakumba RM; Menge R; Kagimu IK; Nakaye C; Babirye JA; Kaganzi H; Lukyamuzi Z; Kizito S; Kuteesa CN; Mujugira A
    AIDS Res Ther; 2021 Apr; 18(1):15. PubMed ID: 33879190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
    Rusine J; Asiimwe-Kateera B; van de Wijgert J; Boer KR; Mukantwali E; Karita E; Gasengayire A; Jurriaans S; de Jong M; Ondoa P
    PLoS One; 2013; 8(8):e64345. PubMed ID: 23950859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
    Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
    PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.